TokenPost·
Blackstone to Fund Pfizer’s Berobenatide Program With Up to $1.5 Billion
The arrangement covers development costs through 2028. Blackstone may receive payments tied to U.S. approval and commercial sales milestones.
More news
- TokenPostMLN Rises 10.4% in an Hour to Its 24-Hour High of $1.38
- TokenPostNvidia Board Weighs Interim CEO as It Searches for Huang’s Successor
- TokenPostGrin Drops 12.9% in Five Minutes to $0.011399 on Nov. 11
- TokenPostBinance Spot Ether Bids Outpace Asks by $726,900 in Snapshot
- TokenPostNvidia Board Weighs Outside Firm to Find Jensen Huang's Successor
- TokenPostBitcoin ETF Outflows Reach $1.88 Billion as Holder Accumulation Narrows